CZIRR JAMES C 4

Accession 0001641172-25-014756

CIK 0001133416other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 6:25 PM ET

Size

37.5 KB

Accession

0001641172-25-014756

Insider Transaction Report

Form 4

Period: 2025-02-03

GALECTIN THERAPEUTICS INCGALT

CZIRR JAMES C

Director10% Owner

Transactions

Exercise/Conversion
Stock Option (right to buy)
2025-06-06−40,000→ 0 total
Exercise: $1.11Exp: 2025-06-07→ Common Stock (40,000 underlying)
Exercise/Conversion
Common Stock
2025-06-06$1.98/sh+40,000$79,200→ 1,005,541 total
Exercise/Conversion
Common Stock
2025-06-06$0.89/sh+31,250$27,813→ 753,666 total
Exercise/Conversion
Common Stock
2025-06-06$2.39/sh+46,875$112,031→ 800,541 total
Exercise/Conversion
Common Stock
2025-06-06$4.72/sh+25,000$118,000→ 825,541 total
Exercise/Conversion
Common Stock
2025-06-06$2.11/sh+40,000$84,400→ 895,541 total
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−25,000→ 220,000 total
Exercise: $4.72Exp: 2025-06-07→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−40,000→ 40,000 total
Exercise: $1.98Exp: 2025-06-07→ Common Stock (40,000 underlying)
Exercise/Conversion
Common Stock
2025-06-06$2.11/sh+70,000$147,700→ 965,541 total
Gift
Common Stock
2025-02-03−10,000→ 731,416 total
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−70,000→ 80,000 total
Exercise: $2.11Exp: 2025-06-07→ Common Stock (70,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−46,875→ 245,000 total
Exercise: $2.39Exp: 2025-06-07→ Common Stock (46,875 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−30,000→ 190,000 total
Exercise: $2.86Exp: 2025-06-07→ Common Stock (30,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−40,000→ 150,000 total
Exercise: $2.11Exp: 2025-06-07→ Common Stock (40,000 underlying)
Exercise/Conversion
Common Stock
2025-06-06$2.86/sh+30,000$85,800→ 855,541 total
Exercise/Conversion
Common Stock
2025-06-06$1.11/sh+40,000$44,400→ 1,045,541 total
Exercise/Conversion
Stock Option (right to buy)
2025-06-06−31,250→ 291,875 total
Exercise: $0.89Exp: 2025-06-07→ Common Stock (31,250 underlying)
Gift
Common Stock
2025-02-04−10,000→ 721,416 total
Other
Common Stock
2025-03-31$6.00/sh+1,000$6,000→ 722,416 total

Footnotes (4)

[F1]Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was paid on 3/31/2025. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend.
[F2]Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9.
[F3]No consideration was received for the shares, which were transferred by gift to relatives.
[F4]Stock options were exercisable at time of exercise.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

GALECTIN THERAPEUTICS INC

CIK 0001133416

→

Entity typeother

Related Parties

filerCIK 0001260641

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 6:25 PM ET
Size: 37.5 KB

View on SEC.gov